HTA Alerts - Med Tech
Subscription service with email alerts about initiated, published and ongoing health technology assessments of medical devices and in-vitro diagnostic tests from 68 HTA organizations globally

Get three-month, free, no-obligation trial to understand the value of the service to your organization
This website uses cookies to ensure you get the best experience on our website. By carrying on browsing, you are giving your consent for us to set cookies.

Learn more

This sub-site ( is no longer updated. Please, proceed to our main web-site to learn about our services (
Health technology assessment (HTA) is a multidisciplinary process that summarizes information about the medical, social, economic and ethical issues related to the use of medical technologies in a systematic, transparent, unbiased, and robust manner.

The key objective of HTA is to advise policymakers and providers about the necessity of adopting and appropriateness of reimbursing procedures, devices, and IVD tests.

Most developed countries have functioning HTA frameworks on different levels (national, regional, and hospital-based). Only in Europe 337 and 256 Med Tech HTA reports were released in 2018 and 2019, respectively.

HTA plays an important role in the market access landscape for medical technologies. Very often, HTA is a formal part of the reimbursement or funding processes (e.g., in France or Norway), or it is not formally connected to the reimbursement process, but it significantly impacts the adoption of technologies (e.g., in England).

Market access professionals closely monitor initiated and published HTAs for the products under their supervision. The key challenges for effective monitoring are the large number of HTA organizations, language barriers, and lack of time to do such monitoring properly.

MTRC offers a unique service of monitoring developments with initiated or published HTA reports for medical technologies globally, so that you do not miss any single HTA for your technology.

This is a twin service with similar activity on key reimbursement news for medical devices (procedure coding, DRG and reimbursement codes, coverage decisions, clinical guidelines developed by governmental organizations) in 15 European countries, "Reimbursement Alerts – Med Tech".

Key features of the service
More than 500 HTA reports (published, initiated, ongoing) are detected every 2 weeks globally (about 300 - in Europe)
  • Global coverage
    The service includes key HTA organizations in Europe and globally (Argentina, Australia, Brazil, Canada, Chile, Colombia, Japan, Malaysia, Mexico, Peru, Singapore, South Africa, South Korea, Taiwan, Thailand, UAE and the USA). In total, 68 active HTA organizations from 36 countries producing Med Tech-related HTA reports are included
  • All reports are classified according to 31 Technology Groups
    The service helps to focus only on technologies of interest (e.g., cardiovascular or neuromodulating devices) and avoid wasting time on not relevant reports
  • All types of HTA organizations are included
    The service includes international (e.g., EUnetHTA), national and regional HTAs. The service includes 68 organizations. Organizations were selected on the basis of an audit of their activity
  • Customized alerts and unlimited number of subscribers
    All reports are customized based on the client's preferences about geographical (you can select only particular countries for monitoring) and technological (e.g., only news for neuromodulation technologies) coverage. The number of enrolled subscribers from one company is unlimited
  • Timely alerts with essential information in English
    Alerts about initiated or published HTAs are sent to email every 2 weeks. For each report, a title, brief summary in English (if available) and the link are provided. You can follow the link to investigate the report further. Every new newsletter covers the last two weeks
  • Reports are developed using a manual search
    We do not trust search robots to identify and classify relevant information. The search and categorization of identified reports is performed manually by MTRC analysts
  • Both general and technology-specific news are included
    The service captures both general (e.g., new program at NICE, or termination of work of Swiss Medical Board) and technology-specific (e.g., new HTA for transcatheter aortic valve implantation) news

Why use "HTA Alerts"?
  • Timely access to essential information
    You can be the first to know about important developments for technology within the company and with your competition. New HTA reports reveal new opportunities for your company's business
  • Ability to engage with HTA stakeholders
    By knowing about initiated assessment, you can engage with HTA bodies in a timely manner to provide relevant information about your technology to increase chances of more unbiased assessment and positive result of HTA
  • Cost-effective approach
    No single Med Tech company can afford such a massive screening and monitoring activity. You outsource an essential function of keeping the company up-to-date at a modest cost. You can save both time and money with an external HTA monitoring service. Both quarterly and annual payments are possible
  • Customized information in a user-friendly format
    You only get access to HTA information for countries (e.g., EMEA only) and technologies (e.g., peripheral vascular) of relevance to your position. Newsletters are easy to navigate and easy to distribute internally
  • Suitable for both middle-size companies and large corporations
    The service is suitable for both middle-size companies with 1-2 people in the market access function and large corporations. For small companies, the service is the only opportunity to keep track of significant developments, and for large corporations, it complements the internal effort
  • More professional fulfillment of the market access role
    Market access professionals use all modern tools at their disposal to execute their function professionally. "HTA Alerts" is becoming a new industry standard and essential tool in the portfolio of market access specialists

A service from a well-known partner
of top-30 Med Tech companies trust MTRC subscription services
154 clients
received support from MTRC over the last three years
19 countries
where MTRC provides regular consulting services
700+ projects
were accomplished since 2017

Contact us to get three-month, free,
no-obligation trial

About MTRC
A specialized Med Tech reimbursement consultancy
17 out of top-30 global Med Tech companies routinely use reimbursement services of MTRC

Coverage of 19 European markets with consulting services

>130 reimbursement projects per year

15 full-time employees, located in six European countries. In-house coverage of key languages (French, German, Italian, Spanish, Polish, Russian, Turkish)

ISO 9001:2015 certified with the United Kingdom Accreditation Service, UKAS

Main web-sites: Med Tech, Online school in market access